Peters David R, Conti Alfredo, Levivier Marc, Schiappacasse Luis, Faouzi Mohamed, Trandafirescu Mioara Florentina, Tuleasca Constantin
Carolina Neurosurgery & Spine Associates, Charlotte, NC, USA.
Mayo Clinic, Rochester, MN, USA.
Brain Spine. 2025 Jan 11;5:104184. doi: 10.1016/j.bas.2025.104184. eCollection 2025.
Cystic brain metastases (BMs) are often more challenging to treat than solid BMs. Stereotactic cyst aspiration for volume reduction followed by stereotactic radiosurgery (SRS) is an alternative treatment modality that may benefit patients with large cystic BMs not favorable for SRS alone nor microsurgical resection.
Here, we perform a systematic review and meta-analysis of stereotactic aspiration alone or reservoir (Ommaya) placement plus aspiration followed by SRS for cystic BMs.
Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we reviewed articles published between 1968 and December 31, 2022. We retained 10 studies reporting 280 patients.
Overall rate of tumor control for combined treatment of Ommaya placement plus aspiration plus SRS was 81.2% (62.5-99.9%, p < 0.001) and for stereotactic aspiration plus SRS was 64.7% (46.1-83.3%, p < 0.001). Overall rate of further intervention for combined treatment of Ommaya placement plus aspiration plus SRS was 15.8% (p = 0.08) and for stereotactic aspiration plus SRS was 14.8% (5.3-24.4%, p = 0.002). Overall complication rate for combined treatment of Ommaya placement plus aspiration plus SRS was 12.8% (2.3-23.3%, p = 0.01) and for stereotactic aspiration plus SRS was 1.5% (p = 0.12).
Combined treatment of Ommaya placement plus cyst aspiration plus SRS in cystic BMs yields better local control as compared to stereotactic aspiration plus SRS, with similar rate of further intervention between procedures. Aspiration of the cyst plus SRS should be considered for patients with cystic metastases not able to undergo open surgery or upfront SRS.
脑囊性转移瘤(BMs)的治疗通常比实性BMs更具挑战性。立体定向囊肿抽吸以减少体积,随后进行立体定向放射外科治疗(SRS)是一种替代治疗方式,可能使那些不适合单独进行SRS或显微手术切除的大型脑囊性转移瘤患者受益。
在此,我们对单独立体定向抽吸或置入储液囊(Ommaya囊)加抽吸后再行SRS治疗脑囊性转移瘤进行系统评价和荟萃分析。
按照系统评价和荟萃分析的首选报告项目(PRISMA)指南,我们检索了1968年至2022年12月31日期间发表的文章。我们纳入了10项报告280例患者的研究。
Ommaya囊置入加抽吸加SRS联合治疗的总体肿瘤控制率为81.2%(62.5-99.9%,p<0.001),立体定向抽吸加SRS的总体肿瘤控制率为64.7%(46.1-83.3%,p<0.001)。Ommaya囊置入加抽吸加SRS联合治疗的进一步干预总体率为15.8%(p = 0.08),立体定向抽吸加SRS的进一步干预总体率为14.8%(5.3-24.4%,p = 0.002)。Ommaya囊置入加抽吸加SRS联合治疗的总体并发症发生率为12.8%(2.3-23.3%,p = 0.01),立体定向抽吸加SRS的总体并发症发生率为1.5%(p = 0.12)。
与立体定向抽吸加SRS相比,Ommaya囊置入加囊肿抽吸加SRS联合治疗脑囊性转移瘤可产生更好的局部控制,两种治疗方法的进一步干预率相似。对于无法接受开放手术或 upfront SRS的囊性转移瘤患者,应考虑囊肿抽吸加SRS治疗。